Brand Name of Cariprazine
The brand name of cariprazine is VRAYLAR 1.
This is the FDA-approved brand name under which cariprazine is marketed in the United States. VRAYLAR is available as oral capsules in strengths of 1.5 mg, 3 mg, 4.5 mg, and 6 mg 1.
The medication received its first global approval in the USA in September 2015 for the treatment of schizophrenia and for acute treatment of manic or mixed episodes associated with bipolar I disorder 2. It has since been approved for additional indications including bipolar depression and as adjunctive therapy for major depressive disorder 3, 4.
VRAYLAR (cariprazine) is an atypical antipsychotic with a unique pharmacological profile as a dopamine D3/D2 receptor partial agonist, with preferential binding to D3 receptors 1, 5. The active ingredient is cariprazine hydrochloride, formulated as hard gelatin capsules for oral administration 1.